dockets: FDA-2025-N-5995
Data license: Public Domain (U.S. Government data) · Data source: U.S. government sources, plus a few identifier registries; each is listed on the methodology page
This data as json
| id | agency_id | title | docket_type | last_modified | object_id | rin | dkabstract | category | subtype | keywords | program | short_title | effective_date | organization | attrs_raw | attr_source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2025-N-5995 | FDA | Effective Date of Requirement for Premarket Approval Applications for Blood Irradiators Intended to Prevent Metastasis | Rulemaking | 2026-03-26T16:49:40Z | 0b000064b9075b4e | Not Assigned | The Food and Drug Administration (FDA) is proposing to require the filing of a premarket approval application (PMA) for blood irradiators intended to irradiate intra-operatively salvaged blood for cancer patients undergoing surgery to assist in prevention of metastasis, which are unclassified, preamendments devices. FDA is summarizing its proposed findings regarding the degree of risk of illness or injury designed to be eliminated or reduced by requiring the devices to meet PMA requirements of the Federal Food, Drug, and Cosmetic Act and the benefits to the public from use of the devices. | ["2024-449", "CDRH", "Notice", "Effective Date of Requirement for", "Premarket Approval Applications for", "Blood Irradiators Intended to Prevent Metastasis", "OPEN"] | CDRH | Effective Date of Requirement for Premarket Approval Applications for Blood Irradiators Intended to Prevent Metastasis | {"displayProperties": [{"name": "generic", "label": "Docket Item Code", "tooltip": "Type of Document That Establishes the Docket"}, {"name": "program", "label": "Center", "tooltip": "The agency specific program associated with the docket (regulatory action); equivalents: Docket Item Code, Location."}, {"name": "field2", "label": "Docket Status", "tooltip": " Used to Identity that a Docket's Status is Open or Closed"}, {"name": "shortTitle", "label": "Short Title", "tooltip": "A combination of letters and or numbers assigned to an agency's regulatory action for purposes of brevity."}], "keywords": ["2024-449", "CDRH", "Notice", "Effective Date of Requirement for", "Premarket Approval Applications for", "Blood Irradiators Intended to Prevent Metastasis", "OPEN"], "modifyDate": "2026-03-26T16:49:40Z", "dkAbstract": "The Food and Drug Administration (FDA) is proposing to require the filing of a premarket approval application (PMA) for blood irradiators intended to irradiate intra-operatively salvaged blood for cancer patients undergoing surgery to assist in prevention of metastasis, which are unclassified, preamendments devices. FDA is summarizing its proposed findings regarding the degree of risk of illness or injury designed to be eliminated or reduced by requiring the devices to meet PMA requirements of the Federal Food, Drug, and Cosmetic Act and the benefits to the public from use of the devices.", "agencyId": "FDA", "program": "CDRH", "shortTitle": "Effective Date of Requirement for Premarket Approval Applications for Blood Irradiators Intended to Prevent Metastasis", "subType2": null, "title": "Effective Date of Requirement for Premarket Approval Applications for Blood Irradiators Intended to Prevent Metastasis", "generic": "N", "field1": null, "docketType": "Rulemaking", "petitionNbr": null, "rin": "Not Assigned", "organization": null, "legacyId": null, "subType": null, "category": null, "field2": "OPEN", "effectiveDate": null, "objectId": "0b000064b9075b4e"} | single_get |
Links from other tables
- 9 rows from docket_id in documents